Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides medical health check-up, medical cold chain logisti...
Kingmed Diagnostics: Third quarter net profit of 5.1973 million yuan, a year-on-year increase of 24.08%
The cancer pathology gene large model DeepGEM is implemented
Kingmed Diagnostics: Has launched testing for Chikungunya virus
Kingmed Diagnostics: Expected net profit loss of RMB 65 million to RMB 95 million in the first half of 2025
Kingmed Diagnostics shareholder Guochuang Kaiyuan plans to reduce its holdings by no more than 1%
The cellular immunotherapy sector has seen a short-term surge, with Staidson BioPharm rising over 10%